Using advanced data analysis to identify genes and drug responses related to diseases.
Integrating multi-omics datasets to infer phenotype-specific driver genes, regulatory interactions and drug response
This study is working on new computer tools that look at a lot of biological information to find out which genes are linked to diseases and how different patients might respond to treatments, all to help create more personalized care for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas NIH-funded |
| Lab location | 1 site (Denton, United States) |
| Project ID | NIH-10663188 on NIH RePORTER |
What this research studies
This research focuses on developing innovative computational tools that analyze large datasets from various biological sources, including genetic and environmental information. By integrating these multi-omics datasets, the research aims to uncover specific genes that drive diseases and predict how patients will respond to different medications. The approach leverages recent advancements in technology to handle vast amounts of data, ultimately contributing to more personalized treatment strategies for patients. The tools created will be open-source, allowing for widespread use and collaboration in the scientific community.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with specific genetic conditions or diseases who may benefit from tailored drug therapies.
Not a fit: Patients with conditions that are not influenced by genetic factors or those who do not have access to the necessary multi-omics data may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients based on their unique genetic profiles.
How similar studies have performed: Previous research has shown promise in using multi-omics approaches to improve understanding of diseases and drug responses, indicating that this methodology has potential for success.
Where this research is happening
Denton, United States
- University of North Texas — Denton, United States (Active)
Researchers
- Principal investigator: Bozdag, Serdar — University of North Texas
- Study coordinator: Bozdag, Serdar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.